LIPOCINE INC. Proceeds from Sale and Maturity of Marketable Securities
LIPOCINE INC. (LPCN) reported Proceeds from Sale and Maturity of Marketable Securities of $6.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2026-08-04
- LIPOCINE INC. proceeds from sale and maturity of marketable securities for the quarter ending 2026-06-30 was $6.50M, a 44.44% increase year-over-year.
- LIPOCINE INC. proceeds from sale and maturity of marketable securities for the quarter ending 2026-03-31 was $5.30M, a 26.19% increase year-over-year.
- LIPOCINE INC. proceeds from sale and maturity of marketable securities for the quarter ending 2025-12-31 was $6.00M, a 42.86% decline year-over-year.
- LIPOCINE INC. proceeds from sale and maturity of marketable securities for the quarter ending 2025-09-30 was $5.90M, a 11.94% decline year-over-year.
- LIPOCINE INC. proceeds from sale and maturity of marketable securities for fiscal 2025 was $20.60M, a 41.81% decline from fiscal 2024.
- LIPOCINE INC. proceeds from sale and maturity of marketable securities for fiscal 2024 was $35.40M, a 1.67% decline from fiscal 2023.
- LIPOCINE INC. proceeds from sale and maturity of marketable securities for fiscal 2023 was $36.00M, a 39.50% decline from fiscal 2022.
- LIPOCINE INC. proceeds from sale and maturity of marketable securities for fiscal 2022 was $59.50M, a 1165.96% increase from fiscal 2021.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.50M 10-Q · filed 2026-08-04 | $11.80M 10-Q · filed 2026-08-04 | $17.80M derived: sum of 3 quarters · filed 2026-08-04 | $23.70M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $5.30M 10-Q · filed 2026-05-07 | $11.30M derived: sum of 2 quarters · filed 2026-05-07 | $17.20M derived: sum of 3 quarters · filed 2026-05-07 | $21.70M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $11.90M derived: sum of 2 quarters · filed 2026-03-10 | $16.40M derived: sum of 3 quarters · filed 2026-08-04 | $20.60M 10-K · filed 2026-03-10 |
| 2025-09-30 | $5.90M 10-Q · filed 2025-11-06 | $10.40M derived: sum of 2 quarters · filed 2026-08-04 | $14.60M 10-Q · filed 2025-11-06 | $25.10M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $4.50M 10-Q · filed 2026-08-04 | $8.70M 10-Q · filed 2026-08-04 | $19.20M derived: sum of 3 quarters · filed 2026-08-04 | $25.90M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $4.20M 10-Q · filed 2026-05-07 | $14.70M derived: sum of 2 quarters · filed 2026-05-07 | $21.40M derived: sum of 3 quarters · filed 2026-05-07 | $32.90M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $10.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $17.20M derived: sum of 2 quarters · filed 2026-03-10 | $28.70M derived: sum of 3 quarters · filed 2026-03-10 | $35.40M 10-K · filed 2026-03-10 |
| 2024-09-30 | $6.70M 10-Q · filed 2025-11-06 | $18.20M derived: sum of 2 quarters · filed 2025-11-06 | $24.90M 10-Q · filed 2025-11-06 | $37.00M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $11.50M 10-Q · filed 2025-08-05 | $18.20M 10-Q · filed 2025-08-05 | $30.30M derived: sum of 3 quarters · filed 2025-08-05 | $36.30M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $6.70M 10-Q · filed 2025-05-08 | $18.80M derived: sum of 2 quarters · filed 2025-05-08 | $24.80M derived: sum of 3 quarters · filed 2025-05-08 | $30.70M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $12.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $18.10M derived: sum of 2 quarters · filed 2025-03-13 | $24.00M derived: sum of 3 quarters · filed 2025-03-13 | $36.00M 10-K · filed 2025-03-13 |
| 2023-09-30 | $6.00M 10-Q · filed 2024-11-07 | $11.90M derived: sum of 2 quarters · filed 2024-11-07 | $23.90M 10-Q · filed 2024-11-07 | $38.10M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $5.90M 10-Q · filed 2024-08-08 | $17.90M 10-Q · filed 2024-08-08 | $32.10M derived: sum of 3 quarters · filed 2024-08-08 | $43.60M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $12.00M 10-Q · filed 2024-05-09 | $26.20M derived: sum of 2 quarters · filed 2024-05-09 | $37.70M derived: sum of 3 quarters · filed 2024-05-09 | $46.30M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $14.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $25.70M derived: sum of 2 quarters · filed 2024-03-07 | $34.30M derived: sum of 3 quarters · filed 2024-03-07 | $59.50M 10-K · filed 2024-03-07 |
| 2022-09-30 | $11.50M 10-Q · filed 2023-11-08 | $20.10M derived: sum of 2 quarters · filed 2023-11-08 | $45.30M 10-Q · filed 2023-11-08 | $46.70M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $8.60M 10-Q · filed 2023-08-10 | $33.80M 10-Q · filed 2023-08-10 | $35.20M derived: sum of 3 quarters · filed 2023-08-10 | $38.00M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $25.20M 10-Q · filed 2023-05-11 | $26.60M derived: sum of 2 quarters · filed 2023-05-11 | $29.40M derived: sum of 3 quarters · filed 2023-05-11 | $29.40M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $4.20M derived: sum of 2 quarters · filed 2023-03-10 | $4.20M derived: sum of 3 quarters · filed 2023-03-10 | $4.70M 10-K · filed 2023-03-10 |
| 2021-09-30 | $2.80M 10-Q · filed 2022-11-09 | $2.80M derived: sum of 2 quarters · filed 2022-11-09 | $3.30M 10-Q · filed 2022-11-09 | $8.65M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-08 | $450.00K 10-Q · filed 2022-08-08 | $5.85M derived: sum of 3 quarters · filed 2022-08-08 | $6.30M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $450.00K 10-Q · filed 2022-05-09 | $5.85M derived: sum of 2 quarters · filed 2022-05-09 | $6.30M derived: sum of 3 quarters · filed 2022-05-09 | $6.30M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $5.85M derived: sum of 2 quarters · filed 2022-03-09 | $5.85M derived: sum of 3 quarters · filed 2022-03-09 | $10.20M 10-K · filed 2022-03-09 |
| 2020-09-30 | $450.00K 10-Q · filed 2021-11-10 | $450.00K derived: sum of 2 quarters · filed 2021-11-10 | $4.80M 10-Q · filed 2021-11-10 | $7.15M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-05 | $4.30M 10-Q · filed 2021-08-05 | $6.70M derived: sum of 3 quarters · filed 2021-08-05 | $15.20M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $4.40M 10-Q · filed 2021-05-06 | $6.70M derived: sum of 2 quarters · filed 2021-05-06 | $15.20M derived: sum of 3 quarters · filed 2021-05-06 | $19.50M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $10.80M derived: sum of 2 quarters · filed 2021-03-11 | $15.10M derived: sum of 3 quarters · filed 2021-03-11 | $19.80M 10-K · filed 2021-03-11 |
| 2019-09-30 | $8.50M 10-Q · filed 2020-11-10 | $12.80M derived: sum of 2 quarters · filed 2020-11-10 | $17.50M 10-Q · filed 2020-11-10 | $27.30M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $4.30M 10-Q · filed 2020-08-06 | $9.00M 10-Q · filed 2020-08-06 | $18.80M derived: sum of 3 quarters · filed 2020-08-06 | $29.20M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $4.70M 10-Q · filed 2019-05-08 | $14.50M derived: sum of 2 quarters · filed 2020-03-13 | $24.90M derived: sum of 3 quarters · filed 2020-03-13 | $29.20M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-12-31 | $9.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $20.20M derived: sum of 2 quarters · filed 2020-03-13 | $24.50M derived: sum of 3 quarters · filed 2020-03-13 | $36.80M 10-K · filed 2020-03-13 |
| 2018-09-30 | $10.40M 10-Q · filed 2019-11-12 | $14.70M derived: sum of 2 quarters · filed 2019-11-12 | $27.00M 10-Q · filed 2019-11-12 | $33.50M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $4.30M 10-Q · filed 2019-08-07 | $16.60M 10-Q · filed 2019-08-07 | $23.10M derived: sum of 3 quarters · filed 2019-08-07 | $31.50M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | $12.30M 10-Q · filed 2019-05-08 | $18.80M derived: sum of 2 quarters · filed 2019-05-08 | $27.20M derived: sum of 3 quarters · filed 2019-05-08 | $40.10M derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | $6.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $14.90M derived: sum of 2 quarters · filed 2019-03-06 | $27.80M derived: sum of 3 quarters · filed 2019-03-06 | $36.20M 10-K · filed 2019-03-06 |
| 2017-09-30 | $8.40M 10-Q · filed 2018-11-07 | $21.30M derived: sum of 2 quarters · filed 2018-11-07 | $29.70M 10-Q · filed 2018-11-07 | $38.60M derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-06-30 | $12.90M 10-Q · filed 2018-08-07 | $21.30M 10-Q · filed 2018-08-07 | $30.20M derived: sum of 3 quarters · filed 2019-03-06 | $41.80M derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-03-31 | $8.40M 10-Q · filed 2018-05-07 | $17.30M derived: sum of 2 quarters · filed 2019-03-06 | $28.90M derived: sum of 3 quarters · filed 2019-03-06 | $33.20M derived: sum of 4 quarters · filed 2019-03-06 |
| 2016-12-31 | $8.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $20.50M derived: sum of 2 quarters · filed 2019-03-06 | $24.80M derived: sum of 3 quarters · filed 2019-03-06 | $28.60M 10-K · filed 2019-03-06 |
| 2016-09-30 | $11.60M 10-Q · filed 2017-11-08 | $15.90M derived: sum of 2 quarters · filed 2017-11-08 | $19.70M 10-Q · filed 2017-11-08 | $20.50M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | $4.30M 10-Q · filed 2017-08-07 | $8.10M 10-Q · filed 2017-08-07 | $8.90M derived: sum of 3 quarters · filed 2018-03-12 | $8.90M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | $3.80M 10-Q · filed 2017-05-08 | $4.60M derived: sum of 2 quarters · filed 2018-03-12 | $4.60M derived: sum of 3 quarters · filed 2018-03-12 | |
| 2015-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $800.00K derived: sum of 2 quarters · filed 2018-03-12 | $800.00K 10-K · filed 2018-03-12 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-08 | $0.00 10-Q · filed 2016-11-08 | ||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-09 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |